WINNIE CHAWIRA: Open Payments
NPI 1528338191 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$478 in 21 payments from 9 companies in 2025. Trend: 2023 $92 · 2024 $167 · 2025 $478
Food & beverage: $478
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $124 |
| GlaxoSmithKline, LLC. | 1 | $121 |
| Novo Nordisk Inc | 4 | $78 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $44 |
| Sumitomo Pharma America, Inc. | 2 | $42 |
| LEO Pharma Inc. | 1 | $27 |
| Radius Health, Inc. | 1 | $19 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $8 |
Products named: PENMENVY, VRAYLAR, Kerendia, GEMTESA, Wegovy, ADBRY, Rybelsus, QULIPTA.
Industry payments across NE — which companies pay providers there.
